RecruitingNCT06730529

The Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases


Sponsor

Ruijin Hospital

Enrollment

40 participants

Start Date

Nov 29, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to investigate the value of 68Ga-FAPI in the preoperative evaluation of thyroid cancer of different pathologic types.


Eligibility

Min Age: 16 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a special type of PET/CT scan using a tracer called 68Ga-FAPI can better detect how far thyroid cancer has spread to nearby lymph nodes before surgery. The goal is to help surgeons plan more precise operations. **You may be eligible if...** - You have been diagnosed with thyroid cancer that has spread to lymph nodes (confirmed by biopsy or imaging) - You are between 16 and 80 years old - You are willing to follow all study procedures **You may NOT be eligible if...** - You have serious heart, lung, bone marrow, liver, or kidney problems - You have a bowel perforation or complete intestinal blockage - You are pregnant, possibly pregnant, or breastfeeding - You are unable or unwilling to follow the study procedures Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06730529


Related Trials